Template:Genital terms: Difference between revisions
From Embryology
mNo edit summary |
mNo edit summary |
||
Line 12: | Line 12: | ||
* '''anorchia''' - (embryonic testicular regression, vanishing testis syndrome) Clinical term for the absence of testes in a 46,XY individual with a male phenotype. Rare abnormality with an incidence of about 1 in 20,000 male births, and occurs more frequently with cryptorchidism (1 in 177 cases). | * '''anorchia''' - (embryonic testicular regression, vanishing testis syndrome) Clinical term for the absence of testes in a 46,XY individual with a male phenotype. Rare abnormality with an incidence of about 1 in 20,000 male births, and occurs more frequently with cryptorchidism (1 in 177 cases). | ||
* '''anti-mullerian hormone''' (AMH, Müllerian Inhibiting Substance, MIS, Müllerian Inhibiting Factor, MIF) A secreted glycoprotein factor (transforming growth factor-beta, [[Developmental Signals - TGF-beta|TGF-beta]] superfamily) that regulates gonadal and genital tract development. In the male embryo, the Sertoli cell secrete AMH and inhibit paramesonephric (Mullerian) duct development. In postnatal males, AMH increases during the first month, reaching peak level at 6 months of age, and then slowly declines during childhood falling to low levels in puberty. In reproductive age women, AMH is produced in the ovary by the granulosa cells surrounding preantral and small antral follicles and serum levels may reflect the remaining follicle cohort and decrease with age. | * '''{{anti-mullerian hormone}}''' ({{AMH}}, Müllerian Inhibiting Substance, MIS, Müllerian Inhibiting Factor, MIF) A secreted glycoprotein factor (transforming growth factor-beta, [[Developmental Signals - TGF-beta|TGF-beta]] superfamily) that regulates gonadal and genital tract development. In the male embryo, the Sertoli cell secrete AMH and inhibit paramesonephric (Mullerian) duct development. In postnatal males, AMH increases during the first month, reaching peak level at 6 months of age, and then slowly declines during childhood falling to low levels in puberty. In reproductive age women, AMH is produced in the ovary by the granulosa cells surrounding preantral and small antral follicles and serum levels may reflect the remaining follicle cohort and decrease with age. {{AMH}} | [[Developmental Signals - TGF-beta|TGF-beta]] | [https://www.omim.org/entry/600957 OMIM - AMH] | ||
* '''Bardet-Biedl syndrome''' - (BBS) is an abnormality with triallelic inheritance and is characterized by a rangne of multisystem abnormalities (cone-rod dystrophy, truncal obesity, postaxial polydactyly, cognitive impairment, neural development, male hypogonadotrophic hypogonadism, complex female genitourinary malformations, and renal dysfunction). | * '''Bardet-Biedl syndrome''' - (BBS) is an abnormality with triallelic inheritance and is characterized by a rangne of multisystem abnormalities (cone-rod dystrophy, truncal obesity, postaxial polydactyly, cognitive impairment, neural development, male hypogonadotrophic hypogonadism, complex female genitourinary malformations, and renal dysfunction). | ||
Line 32: | Line 32: | ||
* '''clomiphene citrate''' - (CC) A fertility drug taken orally to promote the process of [[F#follicle|follicle]]/egg maturation in superovulation therapy. (CC) an anti-estrogen (MRL-41) therapy for WHO group II (eu-oestrogenic) infertility associated with [[P#polycystic ovary syndrome|polycystic ovary syndrome]]. Used for more than 40 years it is a simple, cheap treatment, with low side effects and yields a 25% live birth rate. Alternative therapeutics being considered are metformin, aromatase inhibitors and low-dose FSH. | * '''clomiphene citrate''' - (CC) A fertility drug taken orally to promote the process of [[F#follicle|follicle]]/egg maturation in superovulation therapy. (CC) an anti-estrogen (MRL-41) therapy for WHO group II (eu-oestrogenic) infertility associated with [[P#polycystic ovary syndrome|polycystic ovary syndrome]]. Used for more than 40 years it is a simple, cheap treatment, with low side effects and yields a 25% live birth rate. Alternative therapeutics being considered are metformin, aromatase inhibitors and low-dose FSH. | ||
* '''congenital adrenal hyperplasia''' - (CAH, adrenal virilism) Abnormality of the fetal adrenal cortex, alters cortisol and androgens with different effects dependent upon sex: in females masculization of the external genitalia; in males, disorder often unnoticed until postnatally. In both sexes, accelerated skeletal growth and sexual maturation is seen in late childhood. Caused by a deficiency or absence of the enzyme 21-hydroxylase in the adrenal cortex. Grouped with the Disorders of Sex Development (DSD) and classified by Prader stages. (More? [[Endocrine_-_Adrenal_Development#Congenital_Adrenal_Hyperplasia|congenital adrenal hyperplasia]] | | * '''congenital adrenal hyperplasia''' - (CAH, adrenal virilism) Abnormality of the fetal adrenal cortex, alters cortisol and androgens with different effects dependent upon sex: in females masculization of the external genitalia; in males, disorder often unnoticed until postnatally. In both sexes, accelerated skeletal growth and sexual maturation is seen in late childhood. Caused by a deficiency or absence of the enzyme 21-hydroxylase in the adrenal cortex. Grouped with the Disorders of Sex Development (DSD) and classified by Prader stages. (More? [[Endocrine_-_Adrenal_Development#Congenital_Adrenal_Hyperplasia|congenital adrenal hyperplasia]] | {{adrenal}} | {{genital abnormalities}}) | ||
* ''''Cowper's gland''' - (bulbourethral gland) A male genital tract gland which secretes a small amount of a thick clear mucous fluid prior to ejaculation, the alkaline content apparently buffers acidity of the urethra. The equivalent female genital tract gland is the greater vestibular gland or Bartholin gland. | * ''''Cowper's gland''' - (bulbourethral gland) A male genital tract gland which secretes a small amount of a thick clear mucous fluid prior to ejaculation, the alkaline content apparently buffers acidity of the urethra. The equivalent female genital tract gland is the greater vestibular gland or Bartholin gland. | ||
Line 48: | Line 48: | ||
* '''dihydrotestosterone''' - (DHT) The hormonally active form of testosterone (male sex hormone) produced by enzyme (5-alpha reductase) conversion. In the male embryo, this can occur in the genital skin which then supports external genital development. In the adult, this conversion occurs in a number of different tissues. A known treatment for prostate cancer include 5-alpha reductase inhibitors. | * '''dihydrotestosterone''' - (DHT) The hormonally active form of testosterone (male sex hormone) produced by enzyme (5-alpha reductase) conversion. In the male embryo, this can occur in the genital skin which then supports external genital development. In the adult, this conversion occurs in a number of different tissues. A known treatment for prostate cancer include 5-alpha reductase inhibitors. | ||
* '''Disorder of Sex Development''' - (DSD) A new terminology to describe disorders of sex development. The previous human sex development terminology (intersex, true hermaphrodites, male pseudohermaphrodites and female pseudohermaphrodites) are considered outdated and stigmatising and have been replaced with this general term "Disorders of Sex Development" (DSD) established by the Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. (More? [https://www.ncbi.nlm.nih.gov/pubmed/16882788 PMID 16882788]) | * '''Disorder of Sex Development''' - ({{DSD}}) A new terminology to describe disorders of sex development. The previous human sex development terminology (intersex, true hermaphrodites, male pseudohermaphrodites and female pseudohermaphrodites) are considered outdated and stigmatising and have been replaced with this general term "Disorders of Sex Development" (DSD) established by the Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. (More? [https://www.ncbi.nlm.nih.gov/pubmed/16882788 PMID 16882788]) | ||
* '''ductuli efferentes''' - In the testis (male gonad) series of tubular structures which arise from the rete testis and conduct spermatazoa into the ductus epididymidis. Their columnar epithelium lining consisting of both absorptive and ciliated cells (giving rise to "cogwheel appearance) which removes much of the fluid associated with the spermatazoa leaving the testes (also by the upper epididymis) thereby increasing the spermatazoa concentration. (More? | * '''ductuli efferentes''' - In the testis (male gonad) series of tubular structures which arise from the rete testis and conduct spermatazoa into the ductus epididymidis. Their columnar epithelium lining consisting of both absorptive and ciliated cells (giving rise to "cogwheel appearance) which removes much of the fluid associated with the spermatazoa leaving the testes (also by the upper epididymis) thereby increasing the spermatazoa concentration. (More? {{testis}}) | ||
* '''ductus deferens''' - (vas deferens, Latin, ''deferens'' = carrying-away vessel) The excretory duct of the testis that is the continuation of the canal of the epididymis. Develops from the mesonephric duct. Anatomically beginning at the lower part of the tail of the epididymis it is at first very tortuous, but gradually becoming less twisted it ascends along the posterior border of the testis and medial side of the epididymis, and, as a constituent of the spermatic cord, traverses the inguinal canal to the abdominal inguinal ring. (More? | * '''ductus deferens''' - (vas deferens, Latin, ''deferens'' = carrying-away vessel) The excretory duct of the testis that is the continuation of the canal of the epididymis. Develops from the mesonephric duct. Anatomically beginning at the lower part of the tail of the epididymis it is at first very tortuous, but gradually becoming less twisted it ascends along the posterior border of the testis and medial side of the epididymis, and, as a constituent of the spermatic cord, traverses the inguinal canal to the abdominal inguinal ring. (More? {{testis}}) | ||
* '''ductus epididymidis''' - (epididymidis) male testes tubular structure which arise from the ductuli efferentes and conduct spermatazoa into the [[#ductus_deferens|ductus deferens]] (vas deferens). The long duct is lined by a tall pseudostratified columnar epithelium. | * '''ductus epididymidis''' - (epididymidis) male testes tubular structure which arise from the ductuli efferentes and conduct spermatazoa into the [[#ductus_deferens|ductus deferens]] (vas deferens). The long duct is lined by a tall pseudostratified columnar epithelium. (More? {{testis}}) | ||
* '''epoophoron''' - (rete ovarii, broad ligament cyst) A group of epithelial tubules that can be located in the mesosalpinx possibly mesonephric duct in origin. Occurs when a segment of the mesonephric duct remains in the female, associated with either the ovary and broad ligament. This "male remnant" will appear as a cyst (broad ligament cyst, adnexal papillary cystadenoma of probable mesonephric origin, APMO) with an appearance that differs depending upon the state of differentiation when the original abnormality occurred. | * '''epoophoron''' - (rete ovarii, broad ligament cyst) A group of epithelial tubules that can be located in the mesosalpinx possibly mesonephric duct in origin. Occurs when a segment of the mesonephric duct remains in the female, associated with either the ovary and broad ligament. This "male remnant" will appear as a cyst (broad ligament cyst, adnexal papillary cystadenoma of probable mesonephric origin, APMO) with an appearance that differs depending upon the state of differentiation when the original abnormality occurred. | ||
Line 104: | Line 104: | ||
* '''inguinal canal''' - The anatomical pathway for male testes descent from the abdominal cavity (fetal) into the scrotum. | * '''inguinal canal''' - The anatomical pathway for male testes descent from the abdominal cavity (fetal) into the scrotum. | ||
* '''interstitial cell''' - (Leydig cell) Male gonad (testis) cell that secrete the androgen testosterone, beginning in the fetus. Required for internal and external male genital development. | * '''{{interstitial cell}}''' - (Leydig cell) Male gonad (testis) cell that secrete the androgen testosterone, beginning in the fetus. Required for internal and external male genital development. | ||
* '''Leydig cell''' - (interstitial cell) Male gonad (testis) cell that secrete the androgen testosterone, beginning in the fetus. These cells are named after Franz von Leydig (1821 - 1908) a German scientist who histologically described these cells. | * '''{{Leydig cell}}''' - (interstitial cell) Male gonad (testis) cell that secrete the androgen testosterone, beginning in the fetus. These cells are named after Franz von Leydig (1821 - 1908) a German scientist who histologically described these cells. | ||
* '''ligamentum teres''' - (ligamentum teres uteri, Hunter's ligament) The round ligament of uterus which maintains the ventral uterine position. | * '''ligamentum teres''' - (ligamentum teres uteri, Hunter's ligament) The round ligament of uterus which maintains the ventral uterine position. | ||
Line 126: | Line 126: | ||
* '''orchidometer''' - (orchiometer) A clinical instrument used to measure postnatal testis volume using 12 beads ranging from 1 to 25 millilitres. | * '''orchidometer''' - (orchiometer) A clinical instrument used to measure postnatal testis volume using 12 beads ranging from 1 to 25 millilitres. | ||
* '''ovarian reserve''' - (ovarian reserve markers) Clinical term describing the ability for follicular development in ovaries in response to gonadotropins. This reserve value is relevant for fertility and in vitro fertilization treatments and a number of different ovarian reserve serum and ovarian markers have been identified: baseline follicle stimulating hormone (FSH) levels, baseline anti-Müllerian hormone (AMH) levels, and antral follicle count (AFC). In addition, with reproductive aging there is seen both a quantitative and a qualitative reduction of the primordial follicle pool available. | * '''ovarian reserve''' - (ovarian reserve markers) Clinical term describing the ability for follicular development in ovaries in response to gonadotropins. This reserve value is relevant for fertility and in vitro fertilization treatments and a number of different ovarian reserve serum and ovarian markers have been identified: baseline follicle stimulating hormone (FSH) levels, baseline anti-Müllerian hormone ({{AMH}}) levels, and antral follicle count (AFC). In addition, with reproductive aging there is seen both a quantitative and a qualitative reduction of the primordial follicle pool available. | ||
* '''ovary''' - The two female gonads where female germ cells (oocytes, eggs) are generated and also the source of estrogen and progesterone the female hormones regulating secondary sex characteristics and menstrual cycle uterine changes. The ovary is embryonically formed from primordial germ cells entering region of the paired mesonephric ducts (Wolffian ducts) which are lost in females. | * '''{{ovary}}''' - The two female gonads where female germ cells (oocytes, eggs) are generated and also the source of estrogen and progesterone the female hormones regulating secondary sex characteristics and menstrual cycle uterine changes. The ovary is embryonically formed from primordial germ cells entering region of the paired mesonephric ducts (Wolffian ducts) which are lost in females. | ||
* '''oviduct''' - (uterine horn, fallopian tube, oviduct, salpinx) see uterine tube. A pair of tubular structures designed to transport the oocyte (egg) from the ovary to the uterus body. | * '''oviduct''' - (uterine horn, fallopian tube, oviduct, salpinx) see uterine tube. A pair of tubular structures designed to transport the oocyte (egg) from the ovary to the uterus body. | ||
* '''paramesonephric duct''' - (Müllerian duct) (Greek, para = "beside") The paired ducts that lie beside the mesonephric ducts, that will differentiate in the female embryo to form the female internal genital tract (uterine tubes, uterus, upper vaginal canal). Paramesonephric duct differentiation in females requires Wnt ( | * '''paramesonephric duct''' - (Müllerian duct) (Greek, para = "beside") The paired ducts that lie beside the mesonephric ducts, that will differentiate in the female embryo to form the female internal genital tract (uterine tubes, uterus, upper vaginal canal). Paramesonephric duct differentiation in females requires Wnt ({{WNT}}7a, {{WNT}}5a) signaling through the intracellular β-catenin pathway. | ||
* '''para-urethral gland''' - (Skene gland, Skene's gland, lesser vestibular glands, female prostate gland) Female genital glands on the anterior wall of the vagina and around the lower end of the urethra. Named in 1880 after Alexander Johnston Chalmers Skene (1838-1900) an American gynaecologist. | * '''para-urethral gland''' - (Skene gland, Skene's gland, lesser vestibular glands, female prostate gland) Female genital glands on the anterior wall of the vagina and around the lower end of the urethra. Named in 1880 after Alexander Johnston Chalmers Skene (1838-1900) an American gynaecologist. | ||
Line 146: | Line 146: | ||
* '''seminiferous tubule''' - (spermatogenic epithelium) Male genital testis structure where spermatozoa develop within the wall. Consists of outer smooth muscle layer, spermatogonia, sertoli cells and maturing spermatozoa. | * '''seminiferous tubule''' - (spermatogenic epithelium) Male genital testis structure where spermatozoa develop within the wall. Consists of outer smooth muscle layer, spermatogonia, sertoli cells and maturing spermatozoa. | ||
* '''Sertoli cell''' - The supporting cells in the testes (male gonad) that induce primordial germ cells to commit to sperm development. Support is nutritional and mechanical, as well as forming a blood-testis barrier. In development, these cells secrete anti-Mullerian hormone (AMH), which causes the Mullerian duct (paramesonephric duct) to regress, and help to induce other somatic cells to differentiate into Leydig | * '''{{Sertoli cell}}''' - The supporting cells in the testes (male gonad) that induce primordial germ cells to commit to sperm development. Support is nutritional and mechanical, as well as forming a blood-testis barrier. In development, these cells secrete anti-Mullerian hormone ({{AMH}}), which causes the Mullerian duct (paramesonephric duct) to regress, and help to induce other somatic cells to differentiate into {{Leydig cell}}s. | ||
* '''sex chromosome''' - Term used to describe both the male | * '''sex chromosome''' - Term used to describe both the male {{ChrY}} chromosome and the female {{ChrX}} chromosome. All other chromosomes that are not the sex chromosomes in the genome are described as autosomes. These terms are also used in describing the location or inheritance of genes and/or genetic disorders. | ||
* '''sinovaginal bulbs''' - The caudal ends of the paired mesonephric ducts (Wolffian ducts) thought to be involved in vaginal development, they are under negative control by androgens. | * '''sinovaginal bulbs''' - The caudal ends of the paired mesonephric ducts (Wolffian ducts) thought to be involved in vaginal development, they are under negative control by androgens. | ||
Line 158: | Line 158: | ||
* '''spermatogonia''' - (spermatogonial stem cell) These cells form in the embryo from the primordial germ cell and are located in the seminiferous tubule adjacent to the basal membrane. The cells can either divide and separate to renew the stem cell population, or they divide and stay together as a pair (Apr spermatogonia) connected by an intercellular cytoplasmic bridge to begin to differentiate and eventually form spermatozoa. | * '''spermatogonia''' - (spermatogonial stem cell) These cells form in the embryo from the primordial germ cell and are located in the seminiferous tubule adjacent to the basal membrane. The cells can either divide and separate to renew the stem cell population, or they divide and stay together as a pair (Apr spermatogonia) connected by an intercellular cytoplasmic bridge to begin to differentiate and eventually form spermatozoa. | ||
* '''spermatozoa''' - (spermatozoon, singular term) The male haploid gamete cell produced by meiosis in the testis (male gonad) seminiferous tubule. In humans, produced from puberty onwards and develop from the diploid stem cell the spermatogonia. The developmental meiosis is called spermatogenesis and the final morphologiccal (shape) change is called spermeiogenesis. The mature human spermatozoon formed from the spermatid has a head, neck and tail and is about 60 µm long. At ejaculation these cells undergo capacitation (activation) and become motile. | * '''{{spermatozoa}}''' - (spermatozoon, singular term) The male haploid gamete cell produced by meiosis in the testis (male gonad) seminiferous tubule. In humans, produced from puberty onwards and develop from the diploid stem cell the spermatogonia. The developmental meiosis is called spermatogenesis and the final morphologiccal (shape) change is called spermeiogenesis. The mature human spermatozoon formed from the spermatid has a head, neck and tail and is about 60 µm long. At ejaculation these cells undergo capacitation (activation) and become motile. | ||
* ''testis'' - (Latin testis = "witness", plural testes) Anatomically the male gonad where male germ cells (spermatozoa) are generated and also the source of testosterone (male hormone). Embryonically formed from primordial germ cells entering region of the paired mesonephric ducts (Wolffian ducts) which are preserved in male gonad development and lost in females. | * ''{{testis}}'' - (Latin testis = "witness", plural testes) Anatomically the male gonad where male germ cells (spermatozoa) are generated and also the source of testosterone (male hormone). Embryonically formed from primordial germ cells entering region of the paired mesonephric ducts (Wolffian ducts) which are preserved in male gonad development and lost in females. | ||
* '''testis cord''' - (sex cord) The embryonic precursor of the seminiferous tubule. These form embryonically initially as a complex series of parallel transverse loops separated by interstitial cells. During fetal development these cords elongate and expand leading to the convoluted structure of the seminiferous epithelium. | * '''testis cord''' - (sex cord) The embryonic precursor of the seminiferous tubule. These form embryonically initially as a complex series of parallel transverse loops separated by interstitial cells. During fetal development these cords elongate and expand leading to the convoluted structure of the seminiferous epithelium. | ||
Line 190: | Line 190: | ||
* '''uterine tube''' - (uterine horn, oviduct, fallopian tube, salpinx) A pair of tubular structures that transport the oocyte (egg) from the ovary to the uterus body. They are located laterally on the upper uterus and consist medial to lateral of three main parts: isthmus (medial constricted third), ampulla (intermediate dilated portion) and infundibulum (containing the abdominal opening/ostium, surrounded by finger-like fimbriae). The tube has structurally several layers: a lining mucosa (mix of ciliated and secretory epithelium), a middle muscularis layer (inner circular muscle layer and an outer longitudinal layer) and outer serous layer (peritoneal). | * '''uterine tube''' - (uterine horn, oviduct, fallopian tube, salpinx) A pair of tubular structures that transport the oocyte (egg) from the ovary to the uterus body. They are located laterally on the upper uterus and consist medial to lateral of three main parts: isthmus (medial constricted third), ampulla (intermediate dilated portion) and infundibulum (containing the abdominal opening/ostium, surrounded by finger-like fimbriae). The tube has structurally several layers: a lining mucosa (mix of ciliated and secretory epithelium), a middle muscularis layer (inner circular muscle layer and an outer longitudinal layer) and outer serous layer (peritoneal). | ||
* '''uterus''' - The female internal genital (reproductive) tract forming a hollow muscular walled organ, embryonically derived from the paramesonephric ducts. The human uterus has two uterine tubes (fallopian tubes, oviducts) where the first week of development occurs and a single hollow body where implantation of the blastocyst normally occurs. Following puberty, the non-pregnant uterus (epithelium and underlying stroma) undergoes cyclic changes under the influence of hormones, the menstrual cycle. This cycle of uterine changes ceases during pregnancy. In pregnancy, the uterus contributes the maternal component of the placenta. | * '''{{uterus}}''' - The female internal genital (reproductive) tract forming a hollow muscular walled organ, embryonically derived from the paramesonephric ducts. The human uterus has two uterine tubes (fallopian tubes, oviducts) where the first week of development occurs and a single hollow body where implantation of the blastocyst normally occurs. Following puberty, the non-pregnant uterus (epithelium and underlying stroma) undergoes cyclic changes under the influence of hormones, the menstrual cycle. This cycle of uterine changes ceases during pregnancy. In pregnancy, the uterus contributes the maternal component of the placenta. | ||
* '''vagina''' - Part of female genitalia formed from the paramesonephric duct develops as a muscular tube between the uterus and vestibule. | * '''{{vagina}}''' - Part of female genitalia formed from the paramesonephric duct develops as a muscular tube between the uterus and vestibule. | ||
* '''vulva''' - (Latin, ''volva'' or ''vulva'' = "female genitals"; vulvar vestibule) Term used to describe the external genital organs (genitalia) of the female. | * '''vulva''' - (Latin, ''volva'' or ''vulva'' = "female genitals"; vulvar vestibule) Term used to describe the external genital organs (genitalia) of the female. | ||
Line 198: | Line 198: | ||
* '''Wolffian duct''' - (mesonephric duct, preferred terminology), A developmental duct that runs from the mesonephros to cloaca. The duct in male differentiates to form the ductus deferens and in female the same structure regresses. Historically named after Caspar Friedrich Wolff (1733-1794), a German scientist and early embryology researcher and is said to have established the doctrine of germ layers. | * '''Wolffian duct''' - (mesonephric duct, preferred terminology), A developmental duct that runs from the mesonephros to cloaca. The duct in male differentiates to form the ductus deferens and in female the same structure regresses. Historically named after Caspar Friedrich Wolff (1733-1794), a German scientist and early embryology researcher and is said to have established the doctrine of germ layers. | ||
* ''' | * '''{{ChrX}} chromosome''' - The female sex chromosome, which following sexual reproduction is inherited from each parent in females, and inherited from the mother in males. This inheritence pattern impacts upon the pattern of genetic disease. In females, a single X chromosome is inactivated in each cell. [[X chromosome]] | ||
* '''X | * '''{{X Inactivation}}''' - Process that occurs in all cells within females, each cell has 2 copies of the X chromosome (one from father and one from mother) one of copy of which is randomly inactivated throughout the entire body in order to maintain gene dosage. Recent studies have shown that this process starts in female human preimplantation-stage embryos, by accumulation of Xist RNA on one of the two X chromosomes starting around the 8-cell stage. {{X Inactivation}} | ||
* '''Y chromosome''' - The male sex chromosome which contains the sry gene producing Testis-Determining Factor required for male phenotype and can only be inherited from father. In humans the chromosome contains 200+ genes and consists of 50 million base pairs. Testis-Determining Factor (TDF; Testis-Determining Factor on Y, TDY ) is a protein transcription factor and a member of the high mobility group (HMG)-box family of DNA binding proteins. See also the transcription factor SRY-related protein, SOX9 (SRY-related high-mobility group (HMG) box 9). | * '''Y chromosome''' - The male sex chromosome which contains the sry gene producing Testis-Determining Factor required for male phenotype and can only be inherited from father. In humans the chromosome contains 200+ genes and consists of 50 million base pairs. Testis-Determining Factor (TDF; Testis-Determining Factor on Y, TDY ) is a protein transcription factor and a member of the high mobility group (HMG)-box family of DNA binding proteins. See also the transcription factor SRY-related protein, SOX9 (SRY-related high-mobility group (HMG) box 9). {{ChrY}} Chromosome | ||
|} | |} | ||
{{Terms lists}}<noinclude>[[Category:Genital]][[Category:Terms]][[Category:Glossary]][[Category:Template]]</noinclude> | {{Terms lists}}<noinclude>[[Category:Genital]][[Category:Terms]][[Category:Glossary]][[Category:Template]]</noinclude> |
Revision as of 13:15, 5 June 2018
Genital System Terms (expand to view) |
---|
Note there are additional glossaries associated with spermatozoa, oocyte renal.
|
Other Terms Lists |
---|
Terms Lists: ART | Birth | Bone | Cardiovascular | Cell Division | Endocrine | Gastrointestinal | Genital | Genetic | Head | Hearing | Heart | Immune | Integumentary | Neonatal | Neural | Oocyte | Palate | Placenta | Radiation | Renal | Respiratory | Spermatozoa | Statistics | Tooth | Ultrasound | Vision | Historic | Drugs | Glossary |